Donatella Fiore

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Breast Cancer Cells

Angiotensin Converting Enzyme

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Carla Sardo, Giulia Auriemma, Carmela Mazzacano, Claudia Conte, Virgilio Piccolo, Tania Ciaglia, Marta Denel-Bobrowska, Agnieszka B Olejniczak, Donatella Fiore, Maria Chiara Proto, Patrizia Gazzerro, Rita Patrizia Aquino
Inulin Amphiphilic Copolymer-Based Drug Delivery: Unraveling the Structural Features of Graft Constructs. Pharmaceutics 16 (8) (2024)
Carla Sardo, Giulia Auriemma, Carmela Mazzacano, Claudia Conte, Virgilio Piccolo, Tania Ciaglia, Marta Denel-Bobrowska, Agnieszka B Olejniczak, Donatella Fiore, Maria Chiara Proto, Patrizia Gazzerro, Rita Patrizia Aquino
Inulin Amphiphilic Copolymer-Based Drug Delivery: Unraveling the Structural Features of Graft Constructs. Pharmaceutics 16 (8) (2024)
Maria Chiara Proto, Donatella Fiore, Maurizio Bifulco, Patrizia Gazzerro
Rimonabant and Cannabidiol Rewrite the Interactions between Breast Cancer Cells and Tumor Microenvironment. International journal of molecular sciences 24 (17) (2023)
Donatella Fiore, Maria Chiara Proto, Silvia Franceschelli, Maria Pascale, Maurizio Bifulco, Patrizia Gazzerro
In Vitro Evidence of Statins' Protective Role against COVID-19 Hallmarks. Biomedicines 10 (9) (2022)
Amelia Casamassimi, Monica Rienzo, Erika Di Zazzo, Anna Sorrentino, Donatella Fiore, Maria Chiara Proto, Bruno Moncharmont, Patrizia Gazzerro, Maurizio Bifulco, Ciro Abbondanza
Multifaceted Role of PRDM Proteins in Human Cancer. International journal of molecular sciences 21 (7) (2020)
Donatella Fiore, Patrizia Gazzerro, Maria Chiara Proto, Michele Vasaturo, Fabrizio Dal Piaz, Bruno Marcello Fusco, Cristina Pagano, Chiara Laezza, Maurizio Bifulco, Patrizia Gazzerro
N6-Isopentenyladenosine Inhibits Colorectal Cancer and Improves Sensitivity to 5-Fluorouracil-Targeting FBXW7 Tumor Suppressor. Cancers 11 (10) (2019)